BioForce Nanosciences Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BFNH research report →
Companywww.bioforceeclipse.com
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers.
- CEO
- Steven Gagnon
- IPO
- 2007
- Employees
- 3
- HQ
- Virginia Beach, VA, US
Price Chart
Valuation
- Market Cap
- $18.44M
- P/E
- -51.72
- P/S
- 0.00
- P/B
- -25.57
- EV/EBITDA
- -51.70
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 64.13%
- ROIC
- 49.45%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-489,951 · 0.10%
- EPS
- $-0.04 · -131.55%
- Op Income
- $-489,951
- FCF YoY
- -6.37%
Performance & Tape
- 52W High
- $1.02
- 52W Low
- $0.18
- 50D MA
- $0.59
- 200D MA
- $0.65
- Beta
- -0.30
- Avg Volume
- 1.26K
Get TickerSpark's AI analysis on BFNH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 18, 23 | Ferguson Merle | other | 1,400,000 |
| Oct 17, 23 | Ferguson Merle | other | 1,470,000 |
| Oct 17, 23 | Ferguson Merle | other | 1,470,000 |
| May 12, 23 | Ferguson Merle | other | 500,000 |
| Dec 13, 22 | Ferguson Merle | other | 20,000 |
| Sep 30, 22 | Ferguson Merle | other | 10,000 |
| Dec 4, 20 | KAISER RICHARD KAISER | other | 3,000,000 |
| Dec 4, 20 | KAISER RICHARD KAISER | other | 500,000 |
| Dec 4, 20 | Ferguson Merle | other | 11,000,000 |
| Dec 4, 20 | Ferguson Merle | other | 1,500,000 |
Our BFNH Coverage
We haven't published any research on BFNH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BFNH Report →